vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Ramaco Resources, Inc. (METC). Click either name above to swap in a different company.
Ramaco Resources, Inc. is the larger business by last-quarter revenue ($121.0M vs $83.5M, roughly 1.4× BillionToOne, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs -11.0%, a 17.8% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -27.7%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $-17.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Ramaco Resources, Inc. is a U.S.-based mining company focused on high-grade metallurgical coal production. It operates mining assets across the Appalachian region, supplying products to global steel manufacturing and industrial clients, with core operations centered on sustainable low-cost metallurgical coal extraction and distribution.
BLLN vs METC — Head-to-Head
Income Statement — Q3 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $121.0M |
| Net Profit | $5.7M | $-13.3M |
| Gross Margin | 69.9% | 15.8% |
| Operating Margin | 11.5% | -12.0% |
| Net Margin | 6.8% | -11.0% |
| Revenue YoY | 117.4% | -27.7% |
| Net Profit YoY | 138.3% | -5468.2% |
| EPS (diluted) | $0.10 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $83.5M | $121.0M | ||
| Q2 25 | — | $153.0M | ||
| Q1 25 | — | $134.7M | ||
| Q4 24 | — | $170.9M | ||
| Q3 24 | $38.4M | $167.4M | ||
| Q2 24 | — | $155.3M | ||
| Q1 24 | — | $172.7M | ||
| Q4 23 | — | $202.7M |
| Q3 25 | $5.7M | $-13.3M | ||
| Q2 25 | — | $-14.0M | ||
| Q1 25 | — | $-9.5M | ||
| Q4 24 | — | $3.9M | ||
| Q3 24 | $-14.9M | $-239.0K | ||
| Q2 24 | — | $5.5M | ||
| Q1 24 | — | $2.0M | ||
| Q4 23 | — | $30.0M |
| Q3 25 | 69.9% | 15.8% | ||
| Q2 25 | — | 12.3% | ||
| Q1 25 | — | 15.2% | ||
| Q4 24 | — | 20.4% | ||
| Q3 24 | 52.6% | 19.5% | ||
| Q2 24 | — | 21.0% | ||
| Q1 24 | — | 19.1% | ||
| Q4 23 | — | 31.2% |
| Q3 25 | 11.5% | -12.0% | ||
| Q2 25 | — | -9.1% | ||
| Q1 25 | — | -8.9% | ||
| Q4 24 | — | 3.7% | ||
| Q3 24 | -32.9% | 1.0% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 1.9% | ||
| Q4 23 | — | 18.4% |
| Q3 25 | 6.8% | -11.0% | ||
| Q2 25 | — | -9.1% | ||
| Q1 25 | — | -7.0% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | -38.8% | -0.1% | ||
| Q2 24 | — | 3.6% | ||
| Q1 24 | — | 1.2% | ||
| Q4 23 | — | 14.8% |
| Q3 25 | $0.10 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | $-1.47 | $-0.03 | ||
| Q2 24 | — | $0.08 | ||
| Q1 24 | — | $0.00 | ||
| Q4 23 | — | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $193.8M |
| Total DebtLower is stronger | $55.0M | $116.3M |
| Stockholders' EquityBook value | $-239.5M | $526.9M |
| Total Assets | $327.5M | $849.7M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $195.2M | $193.8M | ||
| Q2 25 | — | $28.1M | ||
| Q1 25 | — | $43.5M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $22.9M | ||
| Q2 24 | — | $27.6M | ||
| Q1 24 | — | $30.5M | ||
| Q4 23 | — | $42.0M |
| Q3 25 | $55.0M | $116.3M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $88.2M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | $91.4M |
| Q3 25 | $-239.5M | $526.9M | ||
| Q2 25 | — | $347.4M | ||
| Q1 25 | — | $355.2M | ||
| Q4 24 | — | $362.8M | ||
| Q3 24 | $-242.9M | $361.8M | ||
| Q2 24 | — | $366.1M | ||
| Q1 24 | — | $372.3M | ||
| Q4 23 | — | $369.6M |
| Q3 25 | $327.5M | $849.7M | ||
| Q2 25 | — | $674.6M | ||
| Q1 25 | — | $685.7M | ||
| Q4 24 | — | $674.7M | ||
| Q3 24 | — | $645.4M | ||
| Q2 24 | — | $659.2M | ||
| Q1 24 | — | $674.0M | ||
| Q4 23 | — | $665.8M |
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | 0.25× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $-1.4M |
| Free Cash FlowOCF − Capex | $6.5M | $-17.5M |
| FCF MarginFCF / Revenue | 7.7% | -14.5% |
| Capex IntensityCapex / Revenue | 8.8% | 13.3% |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-24.7M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $13.8M | $-1.4M | ||
| Q2 25 | — | $-4.3M | ||
| Q1 25 | — | $26.0M | ||
| Q4 24 | — | $15.7M | ||
| Q3 24 | — | $37.4M | ||
| Q2 24 | — | $34.4M | ||
| Q1 24 | — | $25.2M | ||
| Q4 23 | — | $41.6M |
| Q3 25 | $6.5M | $-17.5M | ||
| Q2 25 | — | $-19.8M | ||
| Q1 25 | — | $7.6M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | — | $25.6M | ||
| Q2 24 | — | $20.3M | ||
| Q1 24 | — | $6.5M | ||
| Q4 23 | — | $23.6M |
| Q3 25 | 7.7% | -14.5% | ||
| Q2 25 | — | -13.0% | ||
| Q1 25 | — | 5.6% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | — | 15.3% | ||
| Q2 24 | — | 13.1% | ||
| Q1 24 | — | 3.7% | ||
| Q4 23 | — | 11.6% |
| Q3 25 | 8.8% | 13.3% | ||
| Q2 25 | — | 10.2% | ||
| Q1 25 | — | 13.7% | ||
| Q4 24 | — | 6.2% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | — | 9.1% | ||
| Q1 24 | — | 10.8% | ||
| Q4 23 | — | 8.9% |
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.06× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 6.21× | ||
| Q1 24 | — | 12.40× | ||
| Q4 23 | — | 1.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
METC
| Export Coal Revenues | $73.0M | 60% |
| Domestic Coal Revenues | $48.0M | 40% |
